Chemical Compound
(S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide
CAS Registry Number
37517-28-5
Primary record
(S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide
- 库存
- 3,359 克
- 纯度
- 98.2 %
- CAS
- 37517-28-5
化合物标识与属性
- CAS
- 37517-28-5
- PubChem CID
- 37768
- SMILES
- C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N
- Canonical SMILES
- NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O
名称与同义词
- amikacin
- Lukadin
- amikacine
- Amikacinum
- Amikacina
- Amicacin
- Amikavet
- Amikin
- Potentox
- Arikace
- Amiglyde-V
- Amikacillin
- Kaminax
- Mikavir
- Amikacin Base
- Amikacin hydrate
- Briclin
- Pierami
- Amukin
- Amikacin Dihydrate
- 37517-28-5
- Amikozit
- Amiklin
- AMIKACIN SULFATE
- Antibiotic BB-K 8
- Novamin
- Biclin
- Amikacine [INN-French]
- Amikacinum [INN-Latin]
- Amikacina [INN-Spanish]
- Amikacin free base
- Amikacin (USP)
- Amikacin CRS
- Amikacin anhydrous
- Amikacin disulfate
- Arikayce liposomal
- BB-K8
- Amikin(Disulfate)
- Normon, Amikacina
- Medical, Amikacina
- Amikin (Disulfate)
- ANTIBIOTIC BB-K8
- Amiglyde-V (TN)
- Amikacin (Standard)
- Amikacin (USP/INN)
- Antibiotic BB-K-8
- AT03 - Amikacin
- BB-K 8
- Amikacin (free base)
- RefChem:5541
- Amikacin [USAN:BAN:INN]
- nktr-061
- AMIKACIN [HSDB]
- AMIKACIN [INN]
- AMIKACIN [JAN]
- AMIKACIN [MI]
- AC1Q5JTM
- Amikacin [USP:INN:BAN]
- AMIKACIN [VANDF]
- Amikacin Inhalation Solution
- Prestwick3_000395
- CHEBI:2637
- AMIKACIN [MART.]
- DTXSID3022586
- AMIKACIN [USP-RS]
- AMIKACIN [WHO-DD]
- AMIKACIN [WHO-IP]
- CHEMBL177
- D0Y3MO
- HSDB 3583
- UNII-84319SGC3C
- AC1L1YE8
- C22H43N5O13
- SCHEMBL2985
- DTXCID002586
- LKCWBDHBTVXHDL-RMDFUYIESA-N
- 84319SGC3C
- Amikacin [USAN:INN:BAN]
- BAY 41-6551
- BSPBio_000609
- MLS002207279
- Amikacin & Tumor Necrosis Factor
- EINECS 253-538-5
- MFCD00883675
- BB-K-8
- BPBio1_000671
- HY-B0509AR
- orb1310051
- 37517-28-5 (free base)
- AMIKACIN [EP MONOGRAPH]
- AMIKACIN [USP MONOGRAPH]
- NSC 177001
- NSC-177001
- TD1 - Therapeutic Drug mixture
- BDBM91426
- GTPL10894
- HY-B0509A
- D06AX12
- J01GB06
- MAT2501
- MSK7705
- S01AA21
- 1-N-(L(-)-gamma-Amino-alpha-hydroxybutyryl)kanamycin A
- AMIKACINUM [WHO-IP LATIN]
- cid_16218899
- NSC177001
- BAY41-6551
- MSK7705-100MW
- CID37768
- ZINC8214483
- MSK7705-1000MW
- Tox21_111201
- BBF-00673
- BDBM50237603
- EBC-27355
- MFCD11045969
- MSK7705-100W
- NCGC00093350-02
- STK039706
- AKOS005383276
- MSK7705-1000W
- Tox21_111201_1
- AA29724
- Amikacin Solution in Water, 100ug/mL
- C22-H43-N5-O13
- CS-2712
- DB00479
- Amikacin Solution in Water, 1000ug/mL
- NCGC00093350-03
- NCGC00093350-05
- AS-76985
- H978
- J19.345C
- SMR001306795
- CAS-37517-28-5
- LS-146896
- N1-[(S)-4-Amino-2-hydroxybutyryl]kanamycin A
- AB00513828
- FT-0622273
- NS00006181
- 6462-EP1441224A2
- 6462-EP2292612A2
- 6462-EP2295402A2
- 6462-EP2301544A1
- Amikacin Solution in Methanol/Water, 100ug/mL
- C06820
- D02543
- AB00513828_06
- Amikacin Solution in Methanol/Water, 1000ug/mL
- EN300-7481440
- 1-N-[L(-)-4-amino-2-hydroxybutyryl]kanamycin A
- 517A285
- A823716
- Q408529
- SR-01000722004
- (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
- 1-N-(L-(-)-4-Amino-2-hydroxybutyryl)kanamycin A
- SR-01000722004-6
- an-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide
- BRD-K88043978-315-02-8
- (2S)-4-amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide
- (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide
- Amikacin hydrate, Potency:900 mug/mg - 100MG 100mg
- O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
- (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide
- AMK
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
- (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide
- (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide
- 39831-55-5
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4))-N1-((2S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-
- O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine
- O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
- (2S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)-4-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide
- (2S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-4-((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl)oxy-3-hydroxycyclohexyl)-2-hydroxybutanamide
- (2S)-N-[(1R,2S,3S,4R,5S)-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-azanyl-2-[(2S,3R,4S,5S
- (2S)-N-[(1R,2S,3S,4R,5S)-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-azanyl-2-[(2S,3R,4S,5S ,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]-4-azanyl-2-oxidanyl-butanamide
- (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyr
- (S)-O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-->4)]-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine
- (S)-O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine
- ,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]-4-azanyl-2-oxidanyl-butanamide
- 253-538-5
- 6-O-(3-Amino-3-deoxy-alpha-D-glucopyranosyl)-4-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl)-N1-[(S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-D-streptamine
- 6-O-(3-Amino-3-deoxy-alpha-D-glucopyranosyl)-4-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl)-N1-[(S)-4-amino-2-hydroxybutyryl]-2-deoxy-D-streptamine
- AKN
- Amikacin; 6-O-(3-Amino-3-deoxy-?-d-glucopyranosyl)-4-O-(6-amino-6-deoxy-?-d-glucopyranosyl)-1-N-[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-d-streptamine
- Amikacin; 6-O-(3-Amino-3-deoxy-a-d-glucopyranosyl)-4-O-(6-amino-6-deoxy-a-d-glucopyranosyl)-1-N-[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-d-streptamine
- D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N(SUP 1)-(4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-, (S)-
- D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-N1-[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-
- D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.4)]-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
- D-Streptamine, O-3-amino-3-deoxy-? -D-glucopyranosyl-(1.fwdarw.6)-O-[6-amino-6-deoxy -?-D-glucopyranosyl-(1.fwdarw.4)]-N1-[(2S)- 4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1,4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(16)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(14))-N(1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
- D-Streptamino, O-3-amino-3-desoxi-alfa-D-glucopiranosil-(1->6)-O-[6-amino-6-desoxi-alfa-D-glucopiranosil-(1->4)]-N1-[(2S)-4-amino-2-hidroxi-1-oxobutil]-2-desoxi-
- O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE
- O-3-AMINO-3-DEOXY-alpha-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-alpha-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE